Literature DB >> 10405176

Activation of caspase-3 in axotomized rat retinal ganglion cells in vivo.

P Kermer1, N Klöcker, M Labes, S Thomsen, A Srinivasan, M Bähr.   

Abstract

Recently, we have shown that inhibition of caspase-3-like caspases is the most effective treatment strategy to protect adult rat retinal ganglion cells from secondary death following optic nerve transection. In the present study, we localized active caspase-3 in axotomized retinal ganglion cells in vivo and demonstrated a co-localization of the active p20 fragment and TUNEL-staining in some of these cells. In line with this, we detected an enhanced cleavage and activity of caspase-3 protein in retinal tissue after lesion, while caspase-3 mRNA expression remained unchanged. These data suggest caspase-3 as an important mediator of secondary retinal ganglion cell death following axotomy in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10405176     DOI: 10.1016/s0014-5793(99)00747-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  45 in total

1.  Apoptotic cell death and microglial cell responses in cultured rat retina.

Authors:  Karl Engelsberg; Berndt Ehinger; Johan Wassélius; Kjell Johansson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-27       Impact factor: 3.117

Review 2.  [Programmed cell death in the retina. Molecular mechanisms and therapeutic strategies].

Authors:  P Kermer; M Bähr
Journal:  Ophthalmologe       Date:  2005-07       Impact factor: 1.059

3.  A neuroprotective herbal mixture inhibits caspase-3-independent apoptosis in retinal ganglion cells.

Authors:  Zelda H Cheung; Mason C P Leung; Henry K Yip; Wutian Wu; Flora K W Siu; Kwok-Fai So
Journal:  Cell Mol Neurobiol       Date:  2007-08-21       Impact factor: 5.046

4.  Brain-derived neurotrophic factor-mediated neuroprotection of adult rat retinal ganglion cells in vivo does not exclusively depend on phosphatidyl-inositol-3'-kinase/protein kinase B signaling.

Authors:  N Klöcker; P Kermer; J H Weishaupt; M Labes; R Ankerhold; M Bähr
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

Review 5.  BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells.

Authors:  Margaret E Maes; Cassandra L Schlamp; Robert W Nickells
Journal:  Prog Retin Eye Res       Date:  2017-01-04       Impact factor: 21.198

6.  Reduction of potassium currents and phosphatidylinositol 3-kinase-dependent AKT phosphorylation by tumor necrosis factor-(alpha) rescues axotomized retinal ganglion cells from retrograde cell death in vivo.

Authors:  R Diem; R Meyer; J H Weishaupt; M Bahr
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

7.  Combined suppression of CASP2 and CASP6 protects retinal ganglion cells from apoptosis and promotes axon regeneration through CNTF-mediated JAK/STAT signalling.

Authors:  Vasanthy Vigneswara; Nsikan Akpan; Martin Berry; Ann Logan; Carol M Troy; Zubair Ahmed
Journal:  Brain       Date:  2014-04-10       Impact factor: 13.501

8.  Ameliorative effect of omega-3 on spermatogenesis, testicular antioxidant status and preimplantation embryo development in streptozotocin-induced diabetes in rats.

Authors:  Mehdi Khavarimehr; Vahid Nejati; Mazdak Razi; Gholamreza Najafi
Journal:  Int Urol Nephrol       Date:  2017-06-16       Impact factor: 2.370

9.  Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina.

Authors:  Lidawani Lambuk; Azliana Jusnida Ahmad Jafri; Natasha Najwa Nor Arfuzir; Igor Iezhitsa; Renu Agarwal; Khairul Nizam Bin Rozali; Puneet Agarwal; Nor Salmah Bakar; Methil Kannan Kutty; Ahmad Pauzi Md Yusof; Anna Krasilnikova; Alexander Spasov; Alexander Ozerov; Nafeeza Mohd Ismail
Journal:  Neurotox Res       Date:  2016-08-27       Impact factor: 3.911

10.  Retinal ischemia-induced apoptosis is associated with alteration in Bax and Bcl-x(L) expression rather than modifications in Bak and Bcl-2.

Authors:  Nathalie Produit-Zengaffinen; Constantin J Pournaras; Daniel F Schorderet
Journal:  Mol Vis       Date:  2009-10-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.